To further strengthen our findings, we generated an additional PTEN-knockout (KO) CRC cell line (DLD1, originally PTEN wild-type) using the CRISPR/Cas9 system (Supplementary Fig. S8A). This evidence concerns the gene PTEN and colorectal carcinoma.